Richard Godin/LinkedIn
Sep 15, 2026, 13:50
Richard Godin: Challenges in Diagnosing Homozygous Familial Hypercholesterolemia
Richard Godin, Global Medical Director at Regeneron, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Lipidology, adding:
”Clinicians face important challenges when considering diagnosing their patients with homozygous familial hypercholesterolemia.
My friends and I are happy to share our thoughts on the topic in a recent article published in the journal of clinical lipidology.”
Title: Exploring current challenges in diagnosing homozygous familial hypercholesterolemia: Insights from the historical evolution of diagnostic criteria
Authors: Daniel Gaudet, Richard Godin, Robert S. Rosenson, Gerald F. Watts
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 15, 2026, 15:29Abdul Muqtadir Abbasi: Recognizing Thalassemia Trait Is Essential for Every Physician
-
Sep 15, 2026, 15:17Shehab Mohamed: A New Regional Consensus on HLH Diagnosis and Management
-
Sep 15, 2026, 15:17Sheharyar Raza: Managing Randomness in Artificial Intelligence for Transfusion Medicine
-
Sep 15, 2026, 15:00Sarah Wachtman: Modeling AAV-Based Gene Therapy for Hemophilia A Using Pediatric Liver Organoids
-
Sep 15, 2026, 15:00Ashenafi Tazebew Amare: From Blood Donation to Innovation and Patient Access
-
Sep 15, 2026, 14:56Glanzmann Thrombasthenia Beyond Platelet Transfusion
-
Sep 15, 2026, 14:55Christina Pohlman: The Hidden Complexity of Warfarin Therapy in APS
-
Sep 15, 2026, 14:44Consuela A. Albright: Building a More Connected Sickle Cell Care System
-
Sep 15, 2026, 14:43Andrew Jackson: Cyanosis as a Clue to Central Venous Obstruction